KAFTRIO TABLET FILMOMHULD 37,5/25/50MG

Active substance
IVACAFTOR/TEZACAFTOR/ELEXACAFTOR
Therapeutical formulation
TABLETTEN EN CAPSULES

€ 160.22 € 8,972.55 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Conditions apply to the reimbursement of this medicine.

Own risk

€ 160.22 € 8,972.55

This is the amount charged to your deductible per piece per package.

Strength
37,5/25/50MG
Supplier
VERTEX PHARMACEUTICALS BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/20/1468/002

Conditions

Basic insurance

Elexacaftor/Tezacaftor/Ivacaftor Voorwaarde: uitsluitend in combinatie met ivacaftor voor de behandeling van cystische fibrose (CF) patienten van twee jaar en ouder die tenminste een F508del mutatie hebben in het CFTR-gen.

Variants

See also